Loading viewer...
investor_presentation
Format: PDF investor_presentation
Longeveron is a mid-clinical stage regenerative medicine company developing Lomecel-B™, an allogeneic medicinal signaling cell therapy derived from bone marrow. The company is advancing programs in Alzheimer's Disease and Aging-related Frailty through Phase 2 trials, with recent positive CLEARMIND Phase 2a results in mild-AD and five-year survival data from Phase 1 in Hypoplastic Left Heart Syndrome.
presentation
investor_presentation
48 Pages
Pfizer
investor_presentation
Daseke
Gulfport Energy 2016 Investor Presentation
investor_presentationinvestor_presentation
38 Pages
Gulfport Energy Corporation